(Q31894227)

English

Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

1 reference

based on heuristic

inferred from title

author name string

Maugendre D

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Massart C

2

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

89-96

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Antithyroid Drugs and Graves' Disease: A Prospective Randomized Evaluation of the Efficacy of Treatment Duration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Thyrotropin receptor antibodies: advances and importance of detection techniques in thyroid diseases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Use of Chinese hamster ovary cell lines transfected with cloned human thyrotropin receptor for the measurement of thyroid-stimulating antibodies: advantages and difficulties

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Clinical review 3: The clinical use of thyrotropin receptor antibody measurements

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Measurement of thyroid stimulating immunoglobulins in a new cell line transfected with a functional human TSH receptor (JPO9 cells), compared with an assay using FRTL-5 cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Autoantibodies to the thyrotropin receptor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Comparison of Effects of High and Low Dosage Regimens of Antithyroid Drugs in the Management of Graves’ Hyperthyroidism*

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Autoimmune thyroid disease: further developments in our understanding

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Thyroid-Stimulating Antibodies Predict Hyperthyroidisma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Antithyroid drugs and Graves' disease - prospective randomized assessment of long-term treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01197.X

21 January 2018

Identifiers

10.1046/J.1365-2265.2001.01197.X

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31894227&oldid=1971211377"